facebook-pixel

What we know about clotting with the Johnson & Johnson vaccine — and why the U.S. was right to hit pause

Researchers need to find answers, and consumers need to weigh the various risks even as the CDC allows those vaccinations to resume.

(Mary Altaffer | AP) The Johnson & Johnson COVID-19 vaccine sits on a table at a pop up vaccinations site the Albanian Islamic Cultural Center, in the Staten Island borough of New York, Thursday, April 8, 2021. The U.S “paused” administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

(Mary Altaffer | AP) The Johnson & Johnson COVID-19 vaccine sits on a table at a pop up vaccinations site the Albanian Islamic Cultural Center, in the Staten Island borough of New York, Thursday, April 8, 2021. The U.S “paused” administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

MOST VIEWED